ALKEM - IntraDay Trade Analysis with Live Signals

Last Updated Time : 05 Nov 25, 7:43 am

IntraDay Trade Rating: 4.4

💊 ALKEM shows strong technical momentum, volume surge, and earnings growth — a compelling candidate for intraday trading today.

📈 Positive

• 🔹 MACD at 38.2: Strong bullish crossover supports upward price action.
• 🔹 RSI at 64.5: Bullish zone, indicating strong buying interest without being overbought.
• 🔹 Price Above 50 & 200 DMA: Current price (₹5,665) is above both DMAs (₹5,435 & ₹5,234), confirming trend strength.
• 🔹 Volume Surge: 2.4L vs 1Wk avg of 1.4L — strong intraday participation.
• 🔹 Quarterly PAT Growth: Up from ₹226 Cr to ₹610 Cr, a sharp improvement.
• 🔹 Low Debt: Debt-to-equity ratio of 0.04 reflects financial stability.

⚠️ Limitation

• 🔸 RSI Near Overbought: At 64.5, may trigger short-term profit booking.
• 🔸 PEG Ratio at 2.26: Indicates slightly expensive growth expectations.
• 🔸 Industry PE Higher: Industry PE at 33.1 is slightly above ALKEM’s, suggesting moderate valuation pressure.

🚫 Company Negative News

• 📉 Export Margin Pressure: Analysts cite pricing challenges in US generics segment affecting long-term margins.

✅ Company Positive News

• 💊 Strong Domestic Growth: Continued expansion in branded formulations and chronic therapies in India.
• 📈 EPS of ₹197: Reflects robust earnings base and profitability.

🏦 Industry

• 🧪 Sector: Pharmaceuticals — Branded Formulations & Generics.
• 📊 Industry PE: 33.1, slightly above ALKEM’s PE of 31.5, indicating fair valuation.

📌 Conclusion

• 📉 Intraday Setup: Strong technicals and volume favor upside; ideal for breakout trades with RSI caution.
• 💰 Optimal Buy Price: ₹5,640–₹5,655 (on minor dips).
• 📈 Profit Exit Level: ₹5,700–₹5,740 (near 52-week high zone).
• 🛑 Stop Loss: ₹5,610 (below 50 DMA).
• ⏳ If Holding: Exit if RSI crosses 67 or price fails to hold above ₹5,655 intraday.

I can also compare ALKEM’s intraday setup with other pharma leaders showing similar breakout momentum.